Because we did not find changes in the FLCN mRNA levels between human kidney-tumor pairs although we found difference in the steady-state of FLCN protein, we propose that there is also an important translational component to this regulation, possibly depending on the specificity of different kidney cell populations. This evidence concerns the gene FLCN and medical procedure.